2022 Speaker Faculty

Alison Betts

Vice President of Scientific Collaborations & Fellow of Modeling & Simulation

Applied Biomath

Elizabeth Pham

Senior Scientist

Amgen Inc

Joachim Koch

Senior Director, Head Translational Research & Innovation

Affimed GmbH

Shailee Patel

Research Analyst

Beacon Bispecific – Beacon Targeted Therapies

John Rossi

Senior Vice President, Head of Translational Medicine

Cero Therapeutics Inc.

Kristan Meetze

Vice President, Preclinical & Early Development

Cullinan Oncology

Kristel Kemper

Principal Scientist

Genmab

Sowmya Viswanathan

Sowmya Viswanathan

Scientist

Duke NUS

Angus Sinclair

SVP, Immuno-Oncology

IGM Biosciences

Kader Thiam

Senior Vice President - Discovery – Preclinical Models & Services

Genoway

Natalia Soriano-Sarabia

Assistant Professor

George Washington University

Rick Austin

Vice-President Research

Harpoon Therapeutics

John Maher

Chief Scientific Officer

Leucid Bio

Kate Rochlin

COO

OncoResponse

Pieter Fokko van Loo

Senior Director Oncology- Immunology

Merus NV

Wanjun Chen

Senior Investigator Chief, Mucosal Immunology Section

NIDCR,NIH

David DiLillo

Director, Immuno-Oncology

Regeneron Pharmaceuticals Inc.

George Martin

George Martin

President

Riptide Bioscience

Jessica Kirshner

Senior Director, Oncology & Angiogenesis

Regeneron Pharmaceuticals Inc.

Sebastian Nijman

Founder & Chief Scientific Officer Scenic

Biotech BV

Anke Fuchs

Research Group Leader, Advanced Cellular Therapeutics, Mildred Scheel Nachwuchszentrum P2

University Hospital Carl Gustav Carus

Antara Banerjee

Director, Head Cell Engager Therapies, Oncology Drug Discovery Unit

Takeda Pharmaceutical Co. Ltd.

Floris van Delft

CSO

SynAffix

Jonathan Fisher

NIHR Clinical Lecturer & GOSH Charity Springboard Fellow UCL; GOS Institute of Child Health

UCL

Jennifer Chain

Director - Research & Development

Oklahoma Blood Institute

Raphael Clynes

Vice President, Translational Biology

Xencor